Skip to main content
. 2016 Dec 27;8(5):8436–8446. doi: 10.18632/oncotarget.14246

Figure 1. MRTF-A could promote the resistance to doxorubicin and the expression of Nrf2.

Figure 1

Realtime RT-PCR was performed to quantitatively measure the mRNA level of MRTF-A and Nrf2. n≥3; *, P < 0.05, **, P< 0.01 vs control cells A, D, G, J. and M. Western blotting assay for MRTF-A and Nrf2 B, E, H, K. and N. The figure is representative of at least three independent experiments, and the graphs C, F, I, L. and O. reveal the densitometric quantification of these experiments (*, P < 0.05).